Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle M Walker

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|April 5, 2011
Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosisKyle M Walker, Janet Pope, , et al.
Seminars in Arthritis and Rheumatism|April 3, 2012
Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis expertsKyle M Walker, Janet Pope, , et al.
The Journal of Chemical Physics|July 17, 2016
The first potential energy surfaces for the C6H(-)-H2 and C6H(-)-He collisional systems and their corresponding inelastic cross sectionsKyle M Walker, Fabien Dumouchel, François Lique, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Treatment Algorithms for Systemic Sclerosis According to ExpertsAndreu Fernández-Codina, Kyle M Walker, Janet E Pope, et al.
Rheumatology Advances in Practice|August 22, 2019
Characteristics and outcomes in a prospective cohort of patients with histologically diagnosed aortitisHart A Goldhar, Kyle M Walker, Mohamed Abdelrazek, et al.
Rheumatology (Oxford, England)|May 23, 2014
Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib studyJanet Pope, Kyle M Walker, Faye de Leon, et al.
Immunology and Cell Biology|September 14, 2011
Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonistKyle M Walker, Mateusz Rytelewski, Delfina M Mazzuca, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|April 5, 2011
Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosisKyle M Walker, Janet Pope, , et al.
Seminars in Arthritis and Rheumatism|April 3, 2012
Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis expertsKyle M Walker, Janet Pope, , et al.
The Journal of Chemical Physics|July 17, 2016
The first potential energy surfaces for the C6H(-)-H2 and C6H(-)-He collisional systems and their corresponding inelastic cross sectionsKyle M Walker, Fabien Dumouchel, François Lique, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Treatment Algorithms for Systemic Sclerosis According to ExpertsAndreu Fernández-Codina, Kyle M Walker, Janet E Pope, et al.
Rheumatology Advances in Practice|August 22, 2019
Characteristics and outcomes in a prospective cohort of patients with histologically diagnosed aortitisHart A Goldhar, Kyle M Walker, Mohamed Abdelrazek, et al.
Rheumatology (Oxford, England)|May 23, 2014
Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib studyJanet Pope, Kyle M Walker, Faye de Leon, et al.
Immunology and Cell Biology|September 14, 2011
Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonistKyle M Walker, Mateusz Rytelewski, Delfina M Mazzuca, et al.
Pageof 1